Correlation Between BioAffinity Technologies and Compugen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioAffinity Technologies and Compugen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioAffinity Technologies and Compugen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between bioAffinity Technologies Warrant and Compugen, you can compare the effects of market volatilities on BioAffinity Technologies and Compugen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioAffinity Technologies with a short position of Compugen. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioAffinity Technologies and Compugen.

Diversification Opportunities for BioAffinity Technologies and Compugen

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between BioAffinity and Compugen is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies Warra and Compugen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compugen and BioAffinity Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on bioAffinity Technologies Warrant are associated (or correlated) with Compugen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compugen has no effect on the direction of BioAffinity Technologies i.e., BioAffinity Technologies and Compugen go up and down completely randomly.

Pair Corralation between BioAffinity Technologies and Compugen

Assuming the 90 days horizon bioAffinity Technologies Warrant is expected to generate 25.76 times more return on investment than Compugen. However, BioAffinity Technologies is 25.76 times more volatile than Compugen. It trades about 0.11 of its potential returns per unit of risk. Compugen is currently generating about -0.05 per unit of risk. If you would invest  25.00  in bioAffinity Technologies Warrant on September 1, 2024 and sell it today you would earn a total of  47.00  from holding bioAffinity Technologies Warrant or generate 188.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy92.06%
ValuesDaily Returns

bioAffinity Technologies Warra  vs.  Compugen

 Performance 
       Timeline  
BioAffinity Technologies 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in bioAffinity Technologies Warrant are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, BioAffinity Technologies showed solid returns over the last few months and may actually be approaching a breakup point.
Compugen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Compugen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

BioAffinity Technologies and Compugen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioAffinity Technologies and Compugen

The main advantage of trading using opposite BioAffinity Technologies and Compugen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioAffinity Technologies position performs unexpectedly, Compugen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compugen will offset losses from the drop in Compugen's long position.
The idea behind bioAffinity Technologies Warrant and Compugen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets